Introduction {#Sec1}
============

Ultrasound, computed tomography (CT) and magnetic resonance imaging (MRI) can be used in tissue perfusion studies^[@CR1]--[@CR7]^. In CT, however, there is a linear relationship between the concentration of iodinated contrast media and the recorded density in Hounsfield units^[@CR8]--[@CR10]^, and this could be considered the preferred technique for the acquisition of perfusion images^[@CR11]^. Perfusion CT is a relatively recent technique and can provide qualitative and quantitative information regarding tissue perfusion parameters in a non-invasive way. In comparing perfusion CT and dynamic contrast enhanced MRI, the major drawback of the first method is the use of ionizing radiation, while the second is a more complex and time-consuming method. However, CT is faster and more available than MRI. Furthermore, there are more restrictions in MRI use comparing to CT (e.g., implanted devices, metallic foreign bodies and prostheses). Variability of biomarkers in perfusion CT and dynamic contrast enhanced MRI are similar^[@CR12],[@CR13]^.

In 1995, Miles *et al*.^[@CR14]^ conducted the first study on the feasibility of pancreatic perfusion CT. Since then, a number of studies have used CT to observe normal pancreatic perfusion values, pancreatic perfusion impairments in pancreatic and hepatic diseases and modifications in pancreatic perfusion after oncologic therapy^[@CR8],[@CR11],[@CR15]--[@CR27]^.

However, the effects of observer variability in diagnostic testing can have a potentially large impact^[@CR28]^. In clinical practice, radiologist-dependent factors may contribute to measurement inconsistencies due to variations in measurement technique or experience^[@CR29]--[@CR34]^. Therefore, intra- and interobserver variability must be assessed to guarantee the accuracy of radiologic readings.

Little information is available about intra- and interobserver variability in pancreatic perfusion CT^[@CR35],[@CR36]^. Therefore, the purpose of this study is to measure intra- and interobserver agreement among radiologists with different levels of experience while assessing pancreatic perfusion by CT.

Material and Methods {#Sec2}
====================

Between October 2015 and September 2016, we prospectively analyzed 12 scans from subjects who were referred for abdominal perfusion CT at the Jules Bordet Institute (Brussels, Belgium) for reasons unrelated to pancreatic symptoms or disease. Twenty-seven scans from a CT archive were also included. Informed consent was obtained from all participants that were prospectively included. The study was approved by the Ethics Committee of the Jules Bordet Institute and is in accordance with the Declaration of Helsinki. Exclusion criteria were pregnancy, history of allergic reaction to iodinated contrast media, renal insufficiency and history of pancreatic disease. Patients with altered pancreatic imaging (abnormal volume, morphology and/or composition, or focal lesions) were not excluded.

All patients were scanned in a Siemens Somatom^®^ Force 192-slice scanner (Munich, Germany). The perfusion CT examination was performed in the interval between unenhanced and portal phases. To define a correct delay for the perfusion CT, a test phase was performed after injecting 10 mL of nonionic contrast medium (Iomeron 400), followed by a 21 mL bolus of saline solution after an 8 s delay. For this test phase, a region of interest (ROI) was set on the distal thoracic aorta and 15 images were acquired (1 every 2 s, rotation time: 0.25 s, 40 mAs, 100Kvp), so that a curve of aortic enhancement could be obtained (software DynEva^®^, Siemens). The time required to achieve peak aortic enhancement was used to define the delay for the perfusion CT. Next, 50 mL of nonionic contrast medium (Iomeron 400) were injected through an 18-gauge catheter into an antecubital vein at a flow rate of 4.0 mL/s, followed by a 21 mL chaser bolus of saline solution. Eighty kilovolt peak (kVp) voltage was used for the CT tube. The dynamic imaging sequence consisted of 31 acquisitions of 0.25-second duration (rotation time) at an interval of 1.5 s (cycle time), resulting in a total examination time of 45.45 s. The perfusion sequence covered a craniocaudal width of 24 cm (collimation of 48 × 1.2 mm). A portal phase was acquired with a delay of 70 s after 70 mL of contrast media was injected intravenously at the end of the perfusion CT (Table [1](#Tab1){ref-type="table"}).Table 1Protocol of CT acquisition.CT Scanning parametersPrecontrastPerfusionVenousVoltage (kVp)908090Mean scanning delay after\
contrast injection (s)test\*70Collimation (mm)192 × 0.648 × 1.2128 × 0.6Rotation time (s)0.50.25 (full rotation)\
1.5 (cycle time)0.5Pitch0.60.60.8KernelBr36Br32Br40Slice thickness reconstructed (mm)353Contrast agent dose (mL)5070Contrast injection rate (mL/s)44Number of acquisitions\
Bolus NaCl (mL)Helical31\
21helical\
21\*Depends on test phase.

The images were analyzed by three radiologists (J.L.E. -- reader 1, T.S.G. - reader 2, M.V. -- reader 3) with 25, 16 and six years of experience in abdominal imaging, respectively. Each reader performed two reading sessions with at least a 24 h interval. The image data were processed on a workstation (Syngo.via^®^, Siemens) with commercial perfusion CT software (CT Body Perfusion, Siemens) based on the maximum slope model. Motion correction was performed by using a commercial non-rigid motion correction algorithm (Syngo®.via Body Perfusion, Siemens) to improve anatomical alignment. The following parameters were measured: blood flow (measured in mL/100 mL/min), blood volume (measured in mL/100 mL), time to peak (measured in seconds), and mean transit time (measured in seconds). Arterial input was measured by automatically placed ROI in the abdominal aorta. To obtain perfusion CT parameters, each radiologist manually drew three non-superposable circular ROI (between 1.0 and 2.0 cm²) in the head, three in the body and three in the tail of the pancreas to measure these parameters, avoiding visible vessels and ducts. The mean ROI value for each parameter in each part of the pancreas was considered for analysis. The parameters for the whole pancreas were calculated as the sum of the values of the pancreatic head, body and tail divided by three. An example of perfusion CT image processing is shown in Figs [1](#Fig1){ref-type="fig"}--[3](#Fig3){ref-type="fig"}.Figure 1Perfusion CT: image processing.Figure 2Perfusion CT: ROI positioning in pancreatic tail.Figure 3Perfusion CT: curves for blood flow, blood volume, mean transit time and time to peak.

Statistical analysis {#Sec3}
--------------------

The statistical packages utilized were R-project and SPSS (version 18). Mean and standard deviation were used to describe the analyzed variables. Intraobserver agreement was evaluated by the Bland-Altman method and Student's *t*-test for paired samples. Linear mixed model analysis was performed to determine interobserver reliability, considering session and reader effects. The significance level was set at 0.05. Intraclass correlation coefficients ICCs were also calculated to analyze both intra- and interobserver agreement, interpreted by using the following categories: 0.00--0.10 = virtually none; 0.11--0.40 = slight; 0.41--0.60 = fair; 0.61--0.80 = moderate and 0.81--1.00 = substantial agreement^[@CR37]^.

Approval, accordance and informed consent statement {#Sec4}
---------------------------------------------------

The study was approved by the Ethics Committee of the Jules Bordet Institute (Brussels, Belgium) and is in accordance with the Declaration of Helsinki. Informed consent was obtained from all participants that were prospectively included.

Results {#Sec5}
=======

A total of 39 patients \[men: n = 21 (53.8%)\] were included, with a mean age of 64 years. Seventeen patients had type 2 diabetes mellitus (DM2) and 22 did not. Two patients were excluded due to technical problems, which lead to difficulties in measuring pancreatic perfusion parameters (large ascites and improper contrast media injection).

The Bland-Altman analysis showed no significant intraobserver variability for readers 1 or 2 regarding BF, BV, MTT and TTP; for reader 3, there was significant variability for BF in the pancreatic tail and the whole pancreas (tail - mean difference: 11.49 mL/100 mL/min ± 27.6, 95% limit of agreement: −42.6 ± 65.5, p = 0.016; whole pancreas - mean difference: 6.04 mL/100 mL/min ± 13.0, 95% limit of agreement: −19.4 ± 31.5, p = 0.008) and for MTT in the pancreatic tail and whole pancreas (tail - mean difference: −0.47 s ± 1.2, 95% limit of agreement: −2.92 ± 2.0, p = 0.027; whole pancreas - mean difference: −0.26 s ± 0.8, 95% limit of agreement: −1.7 ± 1.2, p = 0.048). The ICCs showed an overall moderate to substantial agreement for the intraobserver measurements, with the exception of MTT in all pancreatic regions (Table [2](#Tab2){ref-type="table"}). Bland-Altman plots graphics with interobserver variability between readers 1 and 2 in BF, BV, TTP and MTT in the whole pancreas are shown in Fig. [4](#Fig4){ref-type="fig"}. Table [3](#Tab3){ref-type="table"} summarizes the pancreatic perfusion measurements for each session and reader, as well as their respective effects and the interaction effect between session and reader. There were session effects on BF in the pancreatic body (mean difference: 4.5 mL/100 mL/min ± 2.20, p = 0.048) and on MTT in the pancreatic tail (mean difference: 0.28 s ± 0.11, p = 0.021) and the whole pancreas (mean difference: 0.18 s ± 0.06, p = 0.007). There were reader effects on BV in pancreatic head, pancreatic body and the whole pancreas. No session effects were found on BV or TTP and no reader effects were found on BF, MTT or TTP. There were no interaction effects between session and reader for any perfusion parameter. ICCs for the interobserver measurements on pancreatic perfusion CT parameters showed an overall substantial agreement, with the exception of MTT in the body, tail and whole pancreas, where it was only fair (Table [4](#Tab4){ref-type="table"}).Table 2Intraobserver variability. Bland-Altman analysis (mean difference) and ICCs for pancreatic perfusion parameters.Reader 1Reader 2Reader 3(n = 37)(n = 37)(n = 37)Mean difference\
(95% Limit of agreement)ICC (95% Confidence interval)pMean difference (95% Limit of agreement)ICC (95% Confidence interval)pMean difference (95% Limit of agreement)ICC (95% Confidence interval)pBF head−1.78 (−47.9;44.3)0.81 (0.66;0.90)0.657−2.81 (−50.4;44.8)0.80 (0.65;0.89)0.4863.76 (−29.4;36.9)0.88 (0.79;0.94)0.185BF body4.42 (−33.2;42.0)0.88 (0.77;0.93)0.1826.37 (−36.2;48.9)0.84 (0.72;0.92)0.0832.87 (34.8;40.5)0.86 (0.75;0.93)0.369BF tail0.04 (−42.3;42.4)0.83 (0.69;0.91)0.9924.80 (−86.7;96.3)0.52 (0.24;0.72)0.53511.49 (−42.6;65.5)0.68 (0.45;0.83)0.016BF whole pancreas0.89 (−32.4;34.2)0.89 (0.79;0.94)0.7572.79 (−43.3;48.8)0.81 (0.66;0.90)0.4756.04 (−19.4;31.5)0.91 (0.81;0.96)0.008BV head−0.01 (−3.5;3.5)0.85 (0.72;0.92)0.425−0.14 (−3.9;3.6)0.85 (0.73;0.92)0.657−0.09 (−3.8;3.6)0.86 (0.75;0.93)0.768BV body−0.23 (−4.0;3.6)0.86 (0.75;0.93)0.4750.22 (−3.1;3.5)0.87 (0.77;0.93)0.4250.00 (−3.2;3.2)0.90 (0.82;0.95)1BV tail0.24 (−4.3;4.3)0.80 (0.64;0.89)0.9470.22 (4.0;4.4)0.81 (0.66;0.90)0.546−0.37 (−4.0;3.2)0.82 (0.68;0.90)0.227BV whole pancreas0.09 (−2.8;2.6)0.90 (0.81;0.95)0.7010.10 (−2.0;2.9)0.94 (0.88;0.97)0.567−0.15 (−2.5;2.2)0.93 (0.86;0.96)0.441MTT head−0.003 (−2.3;2.3)0.62 (0.37;0.78)0.9850.05 (−2.6;2.7)0.54 (0.26;0.73)0.808−0.17 (−2.4;2.1)0.58 (0.32;0.76)0.365MTT body−0.18 (−2.5;2.2)0.70 (0.49;0.83)0.366−0.28 (−2.2;1.6)0.67 (0.45;0.82)0.093−0.12 (−2.3;2.0)0.58 (0.31;0.76)0.517MTT tail−0.16 (−2.3;2.0)0.65 (0.42;0.80)0.375−0.19 (−3.0;2.6)0.58 (0.32;0.76)0.415−0.47 (−2.92;2.0)0.33 (0.03;0.58)0.027MTT whole pancreas−0.11 (−1.9;1.7)0.69 (0.47;0.83)0.450−0.17 (−2.0;1.6)0.62 (0.38;0.79)0.267−0.26 (−1.7;1.2)0.60 (0.34;0.77)0.048TTP head0.08 (−3.4;3.6)0.78 (0.61;0.88)0.785−0.28 (−2.8;2.7)0.86 (0.74;0.93)0.904−0.03 (−3.4;3.3)0.77 (0.59;0.87)0.923TTP body−0.04 (−2.8;2,7)0.83 (0.69;0.91)0.864−0.23 (−3.5;3.1)0.83 (0.69;0.91)0.407−0.28 (−4.7;4.2)0.64 (0.40;0.80)0.464TTP tail0.47 (−2.6;3.5)0.78 (0.62;0.88)0.0790.08 (−2.9;3.1)0.83 (0.69;0.91)0.744−0.17 (−2.9;2.5)0.81 (0.66;0.90)0.467TTP whole pancreas0.17 (−1.6;2.0)0.92 (0.85;0.96)0.269−0.06 (−1.7;1.6)0.94 (0.89;0.97)0.671−0.16 (−2.1;1.8)0.89 (0.80;0.94)0.352BF: blood flow in mL/100 mL/min; BV: blood volume in mL/100 mL; MTT: mean transit time in s; TTP: time to peak in s; ICC: intraclass correlation coefficient.Figure 4Bland-Altman plots graphics showing interobserver variability between readers 1 and 2 in blood flow (BF, mL/100 mL/min), blood volume (BV, mL/100 mL), time to peak (TTP, seconds) and mean transit time (MTT, seconds); ULA: upper limit of agreement; LLA: lower limit of agreement.Table 3Pancreatic perfusion measurements and effects of session, reader, and interaction between session and reader.Reader 1Reader 2Reader 3Effect of sessionEffect of readerEffect of interaction session\*readerSession 1Session 2Session 1Session 2Session 1Session 2BF head132.87 ± 33.9135.14 ± 39.6130.94 ± 35.8133.76 ± 41.0134.19 ± 36.3130.43 ± 34.60.8170.6210.310BF body142.42 ± 39.2138.13 ± 37.2139.90 ± 36.0133.53 ± 43.3137.12 ± 39.2134.25 ± 34.00.0480.1710.732BF tail144.24 ± 32.7144.84 ± 38.1153.57 ± 42.0148.76 ± 52.5149.01 ± 40.7137.51 ± 31.50.0730.1430.074BF whole pancreas139.85 ± 32.8139.37 ± 35.7141.47 ± 33.2138.68 ± 42.1140.11 ± 35.9134.06 ± 31.30.0870.0860.304BV head15.21 ± 3.315.22 ± 3.115.77 ± 3.515.91 ± 3.615.76 ± 3.615.86 ± 3.50.5890.0270.966BV body15.01 ± 3.315.24 ± 4.016.06 ± 3.415.84 ± 3.215.40 ± 3.715.40 ± 3.60.9850.0450.633BV tail15.72 ± 3.215.74 ± 3.516.51 ± 3.316.29 ± 3.615.90 ± 3.016.27 ± 3.10.7760.1420.484BV whole pancreas15.32 ± 3.015.40 ± 3.116.12 ± 2.916.02 ± 3.115.69 ± 3.115.84 ± 3.10.5910.0090.637MTT head7.51 ± 1.47.52 ± 1.37.84 ± 1.37.79 ± 1.47.71 ± 1.37.89 ± 1.20.6230.0750.673MTT body7.15 ± 1.57.33 ± 1.67.53 ± 1.17.82 ± 1.37.36 ± 1.27.48 ± 1.10.0930.1370.741MTT tail7.14 ± 1.37.30 ± 1.37.25 ± 1.67.44 ± 1.37.19 ± 1.37.67 ± 0.80.0210.4900.515MTT whole pancreas7.27 ± 1.27.38 ± 1.17.51 ± 1.07.68 ± 1.17.42 ± 1.07.68 ± 0.80.0070.2220.819TTP head21.72 ± 2.721.64 ± 2.621.54 ± 2.821.56 ± 2.521.48 ± 2.721.51 ± 2.20.9640.6800.932TTP body21.01 ± 2.321.05 ± 2.421.12 ± 2.921.35 ± 2.721.07 ± 2.621.35 ± 2.70.3500.3640.834TTP tail21.14 ± 2.720.67 ± 2.221.16 ± 2.521.08 ± 2.620.76 ± 2.220.93 ± 2.20.3700.4310.218TTP whole pancreas21.29 ± 2.421.12 ± 2.221.27 ± 2.521.33 ± 2.421.10 ± 2.321.26 ± 2.00.8770.6530.316BF: blood flow in mL/100 mL/min; BV: blood volume in mL/100 mL; MTT: mean transit time in s; TTP: time to peak in s.Table 4Interobserver ICCs and CI 95% for pancreatic perfusion parameters.Reader 1 × 2Reader 1 × 3Reader 2 × 3BF head0.94 (0.88;0.97)0.98 (0.95;0.99)0.97 (0.93;0.98)BF body0.91 (0.83;0.95)0.96 (0.91;0.98)0.94 (0.89;0.97)BF tail0.79 (0.59;0.89)0.92 (0.84;0.96)0.88 (0.75;0.94)BF whole pancreas0.93 (0.86;0.96)0.98 (0.95;0.99)0.96 (0.92;0.98)BV head0.94 (0.86;0.97)0.95 (0.88;0.97)0.97 (0.94;0.99)BV body0.88 (0.76;0.94)0.92 (0.85;0.96)0.93 (0.86;0.97)BV tail0.89 (0.78;0.94)0.89 (0.79;0.94)0.90 (0.81;0.95)BV whole pancreas0.94 (0.84;0.97)0.96 (0.91;0.98)0.97 (0.94;0.98)MTT head0.83 (0.67;0.91)0.87 (0.74;0.94)0.92 (0.85;0.96)MTT body0.56 (0.17;0.77)0.68 (0.37;0.83)0.75 (0.51;0.87)MTT tail0.56 (0.13;0.77)0.64 (0.30;0.81)0.60 (0.23;0.80)MTT whole pancreas0.63 (0.30;0.81)0.77 (0.55;0.88)0.82 (0.65;0.91)TTP head0.94 (0.88;0.97)0.91 (0.82;0.95)0.90 (0.80;0.95)TTP body0.96 (0.92;0.98)0.87 (0.74;0.93)0.83 (0.67;0.91)TTP tail0.94 (0.89;0.97)0.90 (0.80;0.95)0.88 (0.77;0.94)TTP whole pancreas0.98 (0.96;0.99)0.94 (0.88;0.97)0.93 (0.87;0.97)BF: blood flow in mL/100 mL/min; BV: blood volume in mL/100 mL; MTT: mean transit time in s;TTP: time to peak in s; ICC: intraclass correlation coefficient; CI: confidence interval.

Discussion {#Sec6}
==========

Our results showed good overall intraobserver agreement for pancreatic perfusion CT parameters, except for BF in the pancreatic tail for reader 3, who had the least experience, and for MTT in all regions of the pancreas for the three readers. No session effects were found on BV or TTP, and there were no reader effects on BF or MTT. TTP values were not significantly different between readers or reading sessions. However, there were session effects on BF in the pancreatic body and on MTT in the pancreatic tail and the whole pancreas. This is probably because the measurements in the body and the tail of the pancreas are more difficult to obtain due to the smaller thickness and the greater variation of the morphology of the pancreas in these regions. Thus, some variability may occur between different sessions of the same reader. Reader effects were found on BV in the pancreatic head and body and the whole pancreas. The measurements obtained by our less experienced (reader 3), seemed different than those obtained by our two most experienced readers. Possibly this is because no training sessions have been held prior to the measurements, suggesting that training sessions for inexperienced readers should be performed. Of note, BF in the head, BV in the tail, and TTP in all pancreatic regions showed good intraobserver correlation and no significant reader or session effects, which supports the use of these parameters in pancreatic perfusion CT.

Measurement reproducibility and accuracy are of particular interest in radiology, since important clinical decisions are often based on CT measurements^[@CR38],[@CR39]^. Accordingly to McErlean *et al*.^[@CR40]^, "lesion measurements on images should be accurate, reproducible, and performed in a standardized fashion with low rates of intra- and interobserver variability". Li *et al*.^[@CR35]^ reported an interobserver correlation over 0.9 for BF and BV in normal pancreas. Xie *et al*.^[@CR36]^ also observed substantial agreement (0.85). Our study evaluated intraobserver agreement by two methods: Bland-Altman and mixed model analysis; interobserver correlation was evaluated by mixed model analysis, considering session and reader effects. It is important to emphasize that we obtained perfusion measurements in pancreas without lesions, which may not reflect clinical practice where perfusion CT may be used to assess focal pancreatic lesions. This issue could be addressed in forthcoming studies".

This study has some limitations. Our results are based on the readings of only three radiologists. This small number of observers may not truly represent the community of radiologists. The measures obtained by our least experienced reader (reader 3) showed poor intraobserver agreement for BV and MTT in the pancreatic tail and the whole pancreas in the Bland-Altman analysis, suggesting that a preliminary training session, which was not performed in this study, could improve intraobserver results. However, no differences attributable to a single reader were found in mixed model analysis. Second, we only applied maximal slope model to calculate perfusion parameters. There are many other methods that can be used for this purpose, including deconvolution model and dual-input single compartment, and these algorithms are not interchangeable. Although there is no consensus about the best method, maximal slope model is used in the majority of the studies on CT perfusion. Third, some reading sessions of the same patient were performed by a reader with a 24 hour interval. In such a short interval, the intraobserver results can be affected by an observer's recognition of an image (memory bias).

In conclusion, our data support the use of pancreatic perfusion CT by radiologists of different levels of experience. BF in the head, BV in the tail, and TTP in all pancreatic regions seem to be the best parameters to ensure a reasonably reliable reproducibility for pancreatic perfusion CT.
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